Tech Company Financing Transactions
ZBiotics Funding Round
On 3/13/2020, ZBiotics announced $2.3 million in Seed funding from Oyster Funds and private investors.
Transaction Overview
Company Name
Announced On
3/13/2020
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Seed
Investors
Oyster Funds (Lead Investor) (Kenneth Ballenegger)
Proceeds Purpose
The company will use the funds to fuel product development including developing new probiotic solutions, hiring new executives and driving sales growth.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
181 2nd St.
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
Our story begins over a decade ago, when now-CEO Zack Abbott was working at an HIV research lab. There, he learned about how new, enzyme-based drugs could improve human health in profound new ways. However, he also learned that enzymes were so expensive to make that their scope was limited outside of serious drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zack Abbott
Chief Operating Officer
Stephen Lamb
VP - Marketing
Kat Townsend
VP - R & D
John Oliver
Browse more venture capital transactions:
Prev: 3/13/2020: Deep North venture capital transaction
Next: 3/13/2020: Human Interest venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs